DDR deficiency may also increase the sensitivity of tumor to ICI by activating other signaling pathways (73)—for example, in pancreatic tumor, inhibition of ATM increases the expression of tumor type I IFN through a SRC- and TBK1-dependent manner. Here, TBK1 is linked to neoplasm.